Clinic-ready inhibitor of MMP-9/-12 restores sensory and functional decline in rodent models of spinal cord injury

Clin Transl Med. 2022 May;12(5):e884. doi: 10.1002/ctm2.884.

Authors

Zubair Ahmed^{1

2}, Sharif Alhajlah^{1

3}, Adam M Thompson¹, Rebecca J Fairclough⁴

Affiliations

¹ Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Edgbaston, UK.
² Centre for Trauma Sciences Research, University of Birmingham, Edgbaston, UK.
³ Applied Medical Science College, Shaqra University, Addawadmi, Saudi Arabia.
⁴ Emerging Innovations Unit, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, UK.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Matrix Metalloproteinase 9* / genetics
Rodentia
Spinal Cord Injuries* / drug therapy

Substances

Matrix Metalloproteinase 9